世界の高脂血症治療薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Hyperlipidemia Drugs Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5791
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、97ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医薬品

• 販売価格（消費税別）

Single User	￥577,200 (USD3,900)	▷ お問い合わせ
Multi User	￥865,800 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、高脂血症治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（スタチン、胆汁酸封鎖剤、コレステロール吸収阻害剤、フィブリン酸誘導体、その他）、用途別市場規模（病院、歯科クリニック）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・高脂血症治療薬の市場動向
・企業の競争状況、市場シェア
・高脂血症治療薬の種類別市場規模と予測2016-2027（スタチン、胆汁酸封鎖剤、コレステロール吸収阻害剤、フィブリン酸誘導体、その他）
・高脂血症治療薬の用途別市場規模と予測2016-2027（病院、歯科クリニック）
・高脂血症治療薬の北米市場規模2016-2027（アメリカ、カナダ）
・高脂血症治療薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・高脂血症治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・高脂血症治療薬の中南米市場規模2016-2027（メキシコ、ブラジル）
・高脂血症治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（AstraZeneca、Merck & Co., Inc.、Pfizer, Inc.、Daiichi Sankyo、Amgen, Inc.、Sanofi）
・結論

Market Analysis and Insights: Global Hyperlipidemia Drugs Market
The global Hyperlipidemia Drugs market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Hyperlipidemia Drugs market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Hyperlipidemia Drugs market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Hyperlipidemia Drugs market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Hyperlipidemia Drugs market.

Global Hyperlipidemia Drugs Scope and Market Size
Hyperlipidemia Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Hyperlipidemia Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Statins
Bile Acid Sequestrants
Cholesterol Absorption Inhibitors
Fibric Acid Derivatives
Others

Segment by Application
Hospitals
Dental Clinics

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
AstraZeneca
Merck & Co., Inc.
Pfizer, Inc.
Daiichi Sankyo
Amgen, Inc.
Sanofi

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hyperlipidemia Drugs Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Statins
1.2.3 Bile Acid Sequestrants
1.2.4 Cholesterol Absorption Inhibitors
1.2.5 Fibric Acid Derivatives
1.2.6 Others
1.3 Market by Application
1.3.1 Global Hyperlipidemia Drugs Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Dental Clinics
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Hyperlipidemia Drugs Market Perspective (2016-2027)
2.2 Hyperlipidemia Drugs Growth Trends by Regions
2.2.1 Hyperlipidemia Drugs Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Hyperlipidemia Drugs Historic Market Share by Regions (2016-2021)
2.2.3 Hyperlipidemia Drugs Forecasted Market Size by Regions (2022-2027)
2.3 Hyperlipidemia Drugs Industry Dynamic
2.3.1 Hyperlipidemia Drugs Market Trends
2.3.2 Hyperlipidemia Drugs Market Drivers
2.3.3 Hyperlipidemia Drugs Market Challenges
2.3.4 Hyperlipidemia Drugs Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Hyperlipidemia Drugs Players by Revenue
3.1.1 Global Top Hyperlipidemia Drugs Players by Revenue (2016-2021)
3.1.2 Global Hyperlipidemia Drugs Revenue Market Share by Players (2016-2021)
3.2 Global Hyperlipidemia Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Hyperlipidemia Drugs Revenue
3.4 Global Hyperlipidemia Drugs Market Concentration Ratio
3.4.1 Global Hyperlipidemia Drugs Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hyperlipidemia Drugs Revenue in 2020
3.5 Hyperlipidemia Drugs Key Players Head office and Area Served
3.6 Key Players Hyperlipidemia Drugs Product Solution and Service
3.7 Date of Enter into Hyperlipidemia Drugs Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Hyperlipidemia Drugs Breakdown Data by Type
4.1 Global Hyperlipidemia Drugs Historic Market Size by Type (2016-2021)
4.2 Global Hyperlipidemia Drugs Forecasted Market Size by Type (2022-2027)

5 Hyperlipidemia Drugs Breakdown Data by Application
5.1 Global Hyperlipidemia Drugs Historic Market Size by Application (2016-2021)
5.2 Global Hyperlipidemia Drugs Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Hyperlipidemia Drugs Market Size (2016-2027)
6.2 North America Hyperlipidemia Drugs Market Size by Type
6.2.1 North America Hyperlipidemia Drugs Market Size by Type (2016-2021)
6.2.2 North America Hyperlipidemia Drugs Market Size by Type (2022-2027)
6.2.3 North America Hyperlipidemia Drugs Market Size by Type (2016-2027)
6.3 North America Hyperlipidemia Drugs Market Size by Application
6.3.1 North America Hyperlipidemia Drugs Market Size by Application (2016-2021)
6.3.2 North America Hyperlipidemia Drugs Market Size by Application (2022-2027)
6.3.3 North America Hyperlipidemia Drugs Market Size by Application (2016-2027)
6.4 North America Hyperlipidemia Drugs Market Size by Country
6.4.1 North America Hyperlipidemia Drugs Market Size by Country (2016-2021)
6.4.2 North America Hyperlipidemia Drugs Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Hyperlipidemia Drugs Market Size (2016-2027)
7.2 Europe Hyperlipidemia Drugs Market Size by Type
7.2.1 Europe Hyperlipidemia Drugs Market Size by Type (2016-2021)
7.2.2 Europe Hyperlipidemia Drugs Market Size by Type (2022-2027)
7.2.3 Europe Hyperlipidemia Drugs Market Size by Type (2016-2027)
7.3 Europe Hyperlipidemia Drugs Market Size by Application
7.3.1 Europe Hyperlipidemia Drugs Market Size by Application (2016-2021)
7.3.2 Europe Hyperlipidemia Drugs Market Size by Application (2022-2027)
7.3.3 Europe Hyperlipidemia Drugs Market Size by Application (2016-2027)
7.4 Europe Hyperlipidemia Drugs Market Size by Country
7.4.1 Europe Hyperlipidemia Drugs Market Size by Country (2016-2021)
7.4.2 Europe Hyperlipidemia Drugs Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Hyperlipidemia Drugs Market Size (2016-2027)
8.2 Asia-Pacific Hyperlipidemia Drugs Market Size by Type
8.2.1 Asia-Pacific Hyperlipidemia Drugs Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Hyperlipidemia Drugs Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Hyperlipidemia Drugs Market Size by Type (2016-2027)
8.3 Asia-Pacific Hyperlipidemia Drugs Market Size by Application
8.3.1 Asia-Pacific Hyperlipidemia Drugs Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Hyperlipidemia Drugs Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Hyperlipidemia Drugs Market Size by Application (2016-2027)
8.4 Asia-Pacific Hyperlipidemia Drugs Market Size by Region
8.4.1 Asia-Pacific Hyperlipidemia Drugs Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Hyperlipidemia Drugs Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Hyperlipidemia Drugs Market Size (2016-2027)
9.2 Latin America Hyperlipidemia Drugs Market Size by Type
9.2.1 Latin America Hyperlipidemia Drugs Market Size by Type (2016-2021)
9.2.2 Latin America Hyperlipidemia Drugs Market Size by Type (2022-2027)
9.2.3 Latin America Hyperlipidemia Drugs Market Size by Type (2016-2027)
9.3 Latin America Hyperlipidemia Drugs Market Size by Application
9.3.1 Latin America Hyperlipidemia Drugs Market Size by Application (2016-2021)
9.3.2 Latin America Hyperlipidemia Drugs Market Size by Application (2022-2027)
9.3.3 Latin America Hyperlipidemia Drugs Market Size by Application (2016-2027)
9.4 Latin America Hyperlipidemia Drugs Market Size by Country
9.4.1 Latin America Hyperlipidemia Drugs Market Size by Country (2016-2021)
9.4.2 Latin America Hyperlipidemia Drugs Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Hyperlipidemia Drugs Market Size (2016-2027)
10.2 Middle East & Africa Hyperlipidemia Drugs Market Size by Type
10.2.1 Middle East & Africa Hyperlipidemia Drugs Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Hyperlipidemia Drugs Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Hyperlipidemia Drugs Market Size by Type (2016-2027)
10.3 Middle East & Africa Hyperlipidemia Drugs Market Size by Application
10.3.1 Middle East & Africa Hyperlipidemia Drugs Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Hyperlipidemia Drugs Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Hyperlipidemia Drugs Market Size by Application (2016-2027)
10.4 Middle East & Africa Hyperlipidemia Drugs Market Size by Country
10.4.1 Middle East & Africa Hyperlipidemia Drugs Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Hyperlipidemia Drugs Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Details
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca Hyperlipidemia Drugs Introduction
11.1.4 AstraZeneca Revenue in Hyperlipidemia Drugs Business (2016-2021)
11.1.5 AstraZeneca Recent Development
11.2 Merck & Co., Inc.
11.2.1 Merck & Co., Inc. Company Details
11.2.2 Merck & Co., Inc. Business Overview
11.2.3 Merck & Co., Inc. Hyperlipidemia Drugs Introduction
11.2.4 Merck & Co., Inc. Revenue in Hyperlipidemia Drugs Business (2016-2021)
11.2.5 Merck & Co., Inc. Recent Development
11.3 Pfizer, Inc.
11.3.1 Pfizer, Inc. Company Details
11.3.2 Pfizer, Inc. Business Overview
11.3.3 Pfizer, Inc. Hyperlipidemia Drugs Introduction
11.3.4 Pfizer, Inc. Revenue in Hyperlipidemia Drugs Business (2016-2021)
11.3.5 Pfizer, Inc. Recent Development
11.4 Daiichi Sankyo
11.4.1 Daiichi Sankyo Company Details
11.4.2 Daiichi Sankyo Business Overview
11.4.3 Daiichi Sankyo Hyperlipidemia Drugs Introduction
11.4.4 Daiichi Sankyo Revenue in Hyperlipidemia Drugs Business (2016-2021)
11.4.5 Daiichi Sankyo Recent Development
11.5 Amgen, Inc.
11.5.1 Amgen, Inc. Company Details
11.5.2 Amgen, Inc. Business Overview
11.5.3 Amgen, Inc. Hyperlipidemia Drugs Introduction
11.5.4 Amgen, Inc. Revenue in Hyperlipidemia Drugs Business (2016-2021)
11.5.5 Amgen, Inc. Recent Development
11.6 Sanofi
11.6.1 Sanofi Company Details
11.6.2 Sanofi Business Overview
11.6.3 Sanofi Hyperlipidemia Drugs Introduction
11.6.4 Sanofi Revenue in Hyperlipidemia Drugs Business (2016-2021)
11.6.5 Sanofi Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Hyperlipidemia Drugs Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Statins
Table 3. Key Players of Bile Acid Sequestrants
Table 4. Key Players of Cholesterol Absorption Inhibitors
Table 5. Key Players of Fibric Acid Derivatives
Table 6. Key Players of Others
Table 7. Global Hyperlipidemia Drugs Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Hyperlipidemia Drugs Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 9. Global Hyperlipidemia Drugs Market Size by Regions (2016-2021) & (US$ Million)
Table 10. Global Hyperlipidemia Drugs Market Share by Regions (2016-2021)
Table 11. Global Hyperlipidemia Drugs Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 12. Global Hyperlipidemia Drugs Market Share by Regions (2022-2027)
Table 13. Hyperlipidemia Drugs Market Trends
Table 14. Hyperlipidemia Drugs Market Drivers
Table 15. Hyperlipidemia Drugs Market Challenges
Table 16. Hyperlipidemia Drugs Market Restraints
Table 17. Global Hyperlipidemia Drugs Revenue by Players (2016-2021) & (US$ Million)
Table 18. Global Hyperlipidemia Drugs Market Share by Players (2016-2021)
Table 19. Global Top Hyperlipidemia Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hyperlipidemia Drugs as of 2020)
Table 20. Ranking of Global Top Hyperlipidemia Drugs Companies by Revenue (US$ Million) in 2020
Table 21. Global 5 Largest Players Market Share by Hyperlipidemia Drugs Revenue (CR5 and HHI) & (2016-2021)
Table 22. Key Players Headquarters and Area Served
Table 23. Key Players Hyperlipidemia Drugs Product Solution and Service
Table 24. Date of Enter into Hyperlipidemia Drugs Market
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Hyperlipidemia Drugs Market Size by Type (2016-2021) (US$ Million)
Table 27. Global Hyperlipidemia Drugs Revenue Market Share by Type (2016-2021)
Table 28. Global Hyperlipidemia Drugs Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 29. Global Hyperlipidemia Drugs Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 30. Global Hyperlipidemia Drugs Market Size Share by Application (2016-2021) & (US$ Million)
Table 31. Global Hyperlipidemia Drugs Revenue Market Share by Application (2016-2021)
Table 32. Global Hyperlipidemia Drugs Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 33. Global Hyperlipidemia Drugs Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 34. North America Hyperlipidemia Drugs Market Size by Type (2016-2021) (US$ Million)
Table 35. North America Hyperlipidemia Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 36. North America Hyperlipidemia Drugs Market Size by Application (2016-2021) (US$ Million)
Table 37. North America Hyperlipidemia Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 38. North America Hyperlipidemia Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 39. North America Hyperlipidemia Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 40. Europe Hyperlipidemia Drugs Market Size by Type (2016-2021) (US$ Million)
Table 41. Europe Hyperlipidemia Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 42. Europe Hyperlipidemia Drugs Market Size by Application (2016-2021) (US$ Million)
Table 43. Europe Hyperlipidemia Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 44. Europe Hyperlipidemia Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 45. Europe Hyperlipidemia Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Hyperlipidemia Drugs Market Size by Type (2016-2021) (US$ Million)
Table 47. Asia-Pacific Hyperlipidemia Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Hyperlipidemia Drugs Market Size by Application (2016-2021) (US$ Million)
Table 49. Asia-Pacific Hyperlipidemia Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 50. Asia-Pacific Hyperlipidemia Drugs Market Size by Region (2016-2021) & (US$ Million)
Table 51. Asia-Pacific Hyperlipidemia Drugs Market Size by Region (2022-2027) & (US$ Million)
Table 52. Latin America Hyperlipidemia Drugs Market Size by Type (2016-2021) (US$ Million)
Table 53. Latin America Hyperlipidemia Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 54. Latin America Hyperlipidemia Drugs Market Size by Application (2016-2021) (US$ Million)
Table 55. Latin America Hyperlipidemia Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 56. Latin America Hyperlipidemia Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 57. Latin America Hyperlipidemia Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Hyperlipidemia Drugs Market Size by Type (2016-2021) (US$ Million)
Table 59. Middle East & Africa Hyperlipidemia Drugs Market Size by Type (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Hyperlipidemia Drugs Market Size by Application (2016-2021) (US$ Million)
Table 61. Middle East & Africa Hyperlipidemia Drugs Market Size by Application (2022-2027) & (US$ Million)
Table 62. Middle East & Africa Hyperlipidemia Drugs Market Size by Country (2016-2021) & (US$ Million)
Table 63. Middle East & Africa Hyperlipidemia Drugs Market Size by Country (2022-2027) & (US$ Million)
Table 64. AstraZeneca Company Details
Table 65. AstraZeneca Business Overview
Table 66. AstraZeneca Hyperlipidemia Drugs Product
Table 67. AstraZeneca Revenue in Hyperlipidemia Drugs Business (2016-2021) & (US$ Million)
Table 68. AstraZeneca Recent Development
Table 69. Merck & Co., Inc. Company Details
Table 70. Merck & Co., Inc. Business Overview
Table 71. Merck & Co., Inc. Hyperlipidemia Drugs Product
Table 72. Merck & Co., Inc. Revenue in Hyperlipidemia Drugs Business (2016-2021) & (US$ Million)
Table 73. Merck & Co., Inc. Recent Development
Table 74. Pfizer, Inc. Company Details
Table 75. Pfizer, Inc. Business Overview
Table 76. Pfizer, Inc. Hyperlipidemia Drugs Product
Table 77. Pfizer, Inc. Revenue in Hyperlipidemia Drugs Business (2016-2021) & (US$ Million)
Table 78. Pfizer, Inc. Recent Development
Table 79. Daiichi Sankyo Company Details
Table 80. Daiichi Sankyo Business Overview
Table 81. Daiichi Sankyo Hyperlipidemia Drugs Product
Table 82. Daiichi Sankyo Revenue in Hyperlipidemia Drugs Business (2016-2021) & (US$ Million)
Table 83. Daiichi Sankyo Recent Development
Table 84. Amgen, Inc. Company Details
Table 85. Amgen, Inc. Business Overview
Table 86. Amgen, Inc. Hyperlipidemia Drugs Product
Table 87. Amgen, Inc. Revenue in Hyperlipidemia Drugs Business (2016-2021) & (US$ Million)
Table 88. Amgen, Inc. Recent Development
Table 89. Sanofi Company Details
Table 90. Sanofi Business Overview
Table 91. Sanofi Hyperlipidemia Drugs Product
Table 92. Sanofi Revenue in Hyperlipidemia Drugs Business (2016-2021) & (US$ Million)
Table 93. Sanofi Recent Development
Table 94. Research Programs/Design for This Report
Table 95. Key Data Information from Secondary Sources
Table 96. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hyperlipidemia Drugs Market Share by Type: 2020 VS 2027
Figure 2. Statins Features
Figure 3. Bile Acid Sequestrants Features
Figure 4. Cholesterol Absorption Inhibitors Features
Figure 5. Fibric Acid Derivatives Features
Figure 6. Others Features
Figure 7. Global Hyperlipidemia Drugs Market Share by Application: 2020 VS 2027
Figure 8. Hospitals Case Studies
Figure 9. Dental Clinics Case Studies
Figure 10. Hyperlipidemia Drugs Report Years Considered
Figure 11. Global Hyperlipidemia Drugs Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Hyperlipidemia Drugs Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Hyperlipidemia Drugs Market Share by Regions: 2020 VS 2027
Figure 14. Global Hyperlipidemia Drugs Market Share by Regions (2022-2027)
Figure 15. Global Hyperlipidemia Drugs Market Share by Players in 2020
Figure 16. Global Top Hyperlipidemia Drugs Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Hyperlipidemia Drugs as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Hyperlipidemia Drugs Revenue in 2020
Figure 18. Global Hyperlipidemia Drugs Revenue Market Share by Type (2016-2021)
Figure 19. Global Hyperlipidemia Drugs Revenue Market Share by Type (2022-2027)
Figure 20. North America Hyperlipidemia Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Hyperlipidemia Drugs Market Share by Type (2016-2027)
Figure 22. North America Hyperlipidemia Drugs Market Share by Application (2016-2027)
Figure 23. North America Hyperlipidemia Drugs Market Share by Country (2016-2027)
Figure 24. United States Hyperlipidemia Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Hyperlipidemia Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Hyperlipidemia Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Hyperlipidemia Drugs Market Share by Type (2016-2027)
Figure 28. Europe Hyperlipidemia Drugs Market Share by Application (2016-2027)
Figure 29. Europe Hyperlipidemia Drugs Market Share by Country (2016-2027)
Figure 30. Germany Hyperlipidemia Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Hyperlipidemia Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Hyperlipidemia Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Hyperlipidemia Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Hyperlipidemia Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Hyperlipidemia Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Hyperlipidemia Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Hyperlipidemia Drugs Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Hyperlipidemia Drugs Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Hyperlipidemia Drugs Market Share by Region (2016-2027)
Figure 40. China Hyperlipidemia Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Hyperlipidemia Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Hyperlipidemia Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Hyperlipidemia Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Hyperlipidemia Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Hyperlipidemia Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Hyperlipidemia Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Hyperlipidemia Drugs Market Share by Type (2016-2027)
Figure 48. Latin America Hyperlipidemia Drugs Market Share by Application (2016-2027)
Figure 49. Latin America Hyperlipidemia Drugs Market Share by Country (2016-2027)
Figure 50. Mexico Hyperlipidemia Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Hyperlipidemia Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Hyperlipidemia Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Hyperlipidemia Drugs Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Hyperlipidemia Drugs Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Hyperlipidemia Drugs Market Share by Country (2016-2027)
Figure 56. Turkey Hyperlipidemia Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Hyperlipidemia Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Hyperlipidemia Drugs Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. AstraZeneca Revenue Growth Rate in Hyperlipidemia Drugs Business (2016-2021)
Figure 60. Merck & Co., Inc. Revenue Growth Rate in Hyperlipidemia Drugs Business (2016-2021)
Figure 61. Pfizer, Inc. Revenue Growth Rate in Hyperlipidemia Drugs Business (2016-2021)
Figure 62. Daiichi Sankyo Revenue Growth Rate in Hyperlipidemia Drugs Business (2016-2021)
Figure 63. Amgen, Inc. Revenue Growth Rate in Hyperlipidemia Drugs Business (2016-2021)
Figure 64. Sanofi Revenue Growth Rate in Hyperlipidemia Drugs Business (2016-2021)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed

以下、関連資料のご紹介

世界の掻痒治療薬市場規模・現状・予測（2021年-2027年）

Global Pruritus Drugs Market Size, Status and Forecast 2021-2027
QFJ1-5973 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、掻痒治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（局所、経口、非経口）、用途別市場規模（血液性そう痒症、腫瘍性そう痒症、腎性そう痒症、内分泌性そう痒症、胆汁うっ滞性そう痒症）、主要地域別市場規...

世界の脊髄性筋萎縮症（SMA）治療薬市場規模・現状・予測（2021年-2027年）

Global Spinal Muscular Atrophy (SMA) Drugs Market Size, Status and Forecast 2021-2027
QFJ1-4894 2021年6月 87Pages
QYResearch社発行の本調査レポートでは、脊髄性筋萎縮症（SMA）治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口薬、注射薬）、用途別市場規模（乳児、子供、大人）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、...

世界の眼瞼炎薬市場規模・現状・予測（2021年-2027年）

Global Blepharitis Drugs Market Size, Status and Forecast 2021-2027
QFJ1-5625 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、眼瞼炎薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ステロイド、抗生物質）、用途別市場規模（単剤療法、併用薬物療法）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東...

世界の起立性低血圧治療薬市場規模・現状・予測（2021年-2027年）

Global Orthostatic Hypotension Drugs Market Size, Status and Forecast 2021-2027
QFJ1-5919 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、起立性低血圧治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ミドドリン、ノーセラ（ドロキシドパ）、フルドロコルチゾン、その他薬剤）、用途別市場規模（病院、医療研究所、クリニック、その他）、主要地...

世界の気管支拡張症薬市場規模・現状・予測（2021年-2027年）

Global Bronchiectasis Drugs Market Size, Status and Forecast 2021-2027
QFJ1-5637 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、気管支拡張症薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗生物質、去痰薬、その他）、用途別市場規模（病院、研究所、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、...

世界の抗マニア薬市場規模・現状・予測（2021年-2027年）

Global Antimania Drugs Market Size, Status and Forecast 2021-2027
QFJ1-3829 2021年6月 95Pages
QYResearch社発行の本調査レポートでは、抗マニア薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（炭酸リチウム、その他）、用途別市場規模（子供、青少年、中年、高齢者）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、イン...

世界の強迫性障害治療薬市場規模・現状・予測（2021年-2027年）

Global Obsessive-Compulsive Disorder Drugs Market Size, Status and Forecast 2021-2027
QFJ1-5903 2021年6月 97Pages
QYResearch社発行の本調査レポートでは、強迫性障害治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（SSRI、TCA、その他）、用途別市場規模（病院、クリニック、研究所、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、...

世界のゴーシェ病（GD）治療薬市場規模・現状・予測（2021年-2027年）

Global Gaucher Disease (GD) Drugs Market Size, Status and Forecast 2021-2027
QFJ1-5747 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、ゴーシェ病（GD）治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（酵素補充療法、基質減少療法）、用途別市場規模（非神経障害性ゴーシェ病、神経障害性ゴーシェ病）、主要地域別市場規模（北米、アメリカ...

世界の消化器系用医薬品市場規模・現状・予測（2021年-2027年）

Global Digestive Drugs Market Size, Status and Forecast 2021-2027
QFJ1-5705 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、消化器系用医薬品の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（OTC、Rx）、用途別市場規模（病院、診療所）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア...

世界の免疫性血小板減少症治療薬市場規模・現状・予測（2021年-2027年）

Global Immune Thrombocytopenia Drugs Market Size, Status and Forecast 2021-2027
QFJ1-5797 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、免疫性血小板減少症治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（トロンボポエチン受容体作動薬 (TPO-RAs)、コルチコステロイド、静脈免疫グロブリン (IVIGs)、その他薬剤）、用途別市...

世界の胆管がん治療薬市場規模・現状・予測（2021年-2027年） Bile duct connects the liver to the gallbladder and carries bile, which is synthesized by the liver and stored in the gallbladder. The main function of bile is breakdown of fat during digestion. Bile duct cancer is commonly known as cholangiocarcinoma. The specific cause of bile duct cancer is unkno…
酪酸誘導体のグローバル市場2021 Butyric acid derivatives are salts and esters of butyric acid also known as botanoic acid. Salts of butyric acid are predominant segment of butyric acid derivatives market. Salts of butyric acid include sodium butyrate, calcium butyrate, potassium butyrate, magnesium butyrate etc. Of these salts, so…
世界の鼻ポリープ治療薬市場規模・現状・予測（2021年-2027年） Nasal polyps (NP) are noncancerous growths within the nose or sinuses. Symptoms include trouble breathing through the nose, loss of smell, decreased taste, post nasal drip, and a runny nose. The growths are sac-like, movable, and nontender, though face pain may occasionally occur. They typically occ…
世界の抗うつ薬市場規模・現状・予測（2021年-2027年） Antidepressants are medications that can help relieve symptoms of depression, social anxiety disorder, anxiety disorders, seasonal affective disorder, and dysthymia, or mild chronic depression, as well as other conditions. Market Analysis and Insights: Global Antidepressants Drugs Market The global …
アクリル酸＆その誘導体のグローバル市場2021 Acrylic acid is an organic compound with the formula CH2=CHCO2H. It is the simplest unsaturated carboxylic acid, consisting of a vinyl group connected directly to a carboxylic acid terminus. This colorless liquid has a characteristic acrid or tart smell. It is miscible with water, alcohols, ethers, …